Literature DB >> 6683181

A dose-surviving fraction curve for mouse colonic mucosa.

S L Tucker, H R Withers, K A Mason, H D Thames.   

Abstract

A dose-surviving fraction curve representing the response of the mouse colonic mucosa to single doses of 137Cs gamma radiation was obtained from the results of a multifraction in vivo colony assay. Construction of the curve required an estimate of the average number of clonogens initially present per colonic crypt. The estimated clonogen count (88) was determined by a statistical method based on the use of doses per fraction common to different fractionation protocols. Parameters for the LQ and TC models of cell survival were obtained by weighted least-squares fits to the data. A comparison of the survival characteristics of cells from the mouse colonic and jejunal crypts suggested that the epithelium of the colon is less radiosensitive than that of the jejunum.

Entities:  

Mesh:

Year:  1983        PMID: 6683181     DOI: 10.1016/0277-5379(83)90143-8

Source DB:  PubMed          Journal:  Eur J Cancer Clin Oncol        ISSN: 0277-5379


  4 in total

Review 1.  The first James Kirk memorial lecture. What next in fractionated radiotherapy?

Authors:  J F Fowler
Journal:  Br J Cancer Suppl       Date:  1984

2.  Tissue repair capacity and repair kinetics deduced from multifractionated or continuous irradiation regimens with incomplete repair.

Authors:  H D Thames; H R Withers; L J Peters
Journal:  Br J Cancer Suppl       Date:  1984

3.  An amino acid-based oral rehydration solution (AA-ORS) enhanced intestinal epithelial proliferation in mice exposed to radiation.

Authors:  Liangjie Yin; Reshu Gupta; Lauren Vaught; Astrid Grosche; Paul Okunieff; Sadasivan Vidyasagar
Journal:  Sci Rep       Date:  2016-11-23       Impact factor: 4.379

4.  Hedgehog inhibition enhances efficacy of radiation and cisplatin in orthotopic cervical cancer xenografts.

Authors:  Naz Chaudary; Melania Pintilie; David Hedley; Richard P Hill; Michael Milosevic; Helen Mackay
Journal:  Br J Cancer       Date:  2016-11-22       Impact factor: 7.640

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.